Chronic kidney disease in the Ecuadorian population and its impact on transplant activity
DOI:
https://doi.org/10.47464/MetroCiencia/vol31/3/2023/28-38Keywords:
Transplantological activity, chronic kidney disease, replacement therapyAbstract
Introduction: Chronic kidney disease (CKD) is a public health problem that affects millions of people around the world, including Ecuador. CKD not only has a significant impact on the quality of life of patients, but also imposes a substantial economic and social burden on healthcare systems. In this context, transplant activity has become a vital treatment option for patients with CKD in advanced stages. Methodology: A quantitative, observational, descriptive study was carried out, with a cross-sectional cohort design, with the objective of knowing the situational status of chronic kidney disease in the country. The analysis was performed based on descriptive statistics. Result: In Ecuador, during the year 2022, five hundred and ninety-seven (N:597) transplants of organs, tissues, and cells were performed. The rate of kidney transplants per million inhabitants (TMTT) in 2022 was 8.34. From January to May 2023, the number of kidney transplants performed was sixty-four (N: 64). Conclusions: At the moment there are eighteen thousand eighty-six (N:18,086) patients in renal replacement therapy but only eight hundred thirty-five (N:835) are registered in the LEUN awaiting a kidney transplant. This indicates that only 4% of dialysis patients are on the waiting list for a kidney transplant.
Downloads
References
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb; 39(2): p. S1-266.
Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronickidney disease: a prospective study of 23, 534 men and women inWashington countr. J Am Soc Nephrol. 2003 Nov; 14(11): p. 2934-2941.
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 Jun; 67(6): p. 2089-100.
OMS. Organización Mundial de la Salud. [Online].; 2023. Available from: https://www.who.int/es/news-room/fact-sheets/detail/chronic-kidney-disease.
CKD Work Group. CKD Evaluation and Management. [Online].; 2013. Available from: https://kdigo.org/guidelines/ckd-evaluation-and-management/.
Corral Molina JM, Luque Gálvez P, Alcover García JB. Potenciales beneficios del trasplante renal de donante vivo. Arch. Esp. Urol. 2005 Oct; 56(6): p. 485-9.
Valdivia Arencibia J, Gutiérrez Gutiérrez C, Daymiris Méndez F, Delgado Almora E, Treto Ramírez J. Supervivencia en pacientes con trasplante renal. Factores pronósticos. Invest. Medicoquir. 2013; 5(2): p. 253-75.
Carrillo Algarra AJ, Moreno Rubio F, Milena Buitrago S. Enfermedad renal crónica y trasplante renal: experiencias y superación de una estudiante de medicina. Index de Enfermería. 2015; 24(4): p. 250-254.
Espinel Lalama EM, Castillo Muñoz ME, Espín Vaca ES. Estado actual de la actividad trasplantológica en el Ecuador. MetroCiencia. 2023; 31(1): p. 36-50.
Hill NR FSOJea. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One.. 2016;: p. 11(7):e0158765.
Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020 May; 16(5): p. 269-288.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S. Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888): p. 260-272.
Rodrigo Orozco B. Prevención y tratamiento de la enfermedad renal crónica (ERC). Revista Médica Clínica Las Condes. 2010; 21(5): p. 779-789.
Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000; 160(5): p. 685-693.
Canseco J, Luviano J, Macías M. Beneficios clínicos de la terapia de remplazo renal continua en el paciente críticamente enfermo con falla renal aguda. Rev Asoc Mex Med Crit y Ter Int. 2010; 24(2): p. 66-71.
Sosa-Medellín M, Luviano-García J. Terapia de reemplazo renal continua. Conceptos, indicaciones y aspectos básicos de su programación. Med Int Méx. 2018; 34(2): p. 288-298.
Wolfe R, Ashby V, Milford E. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 2019; 341(23): p. 1725-1730.
Nalesso F, Giuliani A, Basso F, Brendolan A. Tiempo y dosis en terapia de remplazo renal. Cir Cir. 2013; 81(1): p. 177-180.
Campbell K, Ash S, Bauer J, Davies P. Impact of nutrition intervention on dietary intake and nutrition risk in the adult oncology population: a systematic review. J Nutr Sci. 2014; 3(e29).
García de Vinuesa S. Factores de progresión de la enfermedad renal crónica. Prevención secundaria. J Nefrología. 2008; 28(S3): p. 17-21.
Knoll G, Cantarovich M. Kidney transplantation in the highly sensitized patient: a Canadian perspective. Can J Kidney Health Dis. 2014; 1(21):
Downloads
Published
Issue
Section
License
Copyright (c) 2023 María Esther Castillo Muñoz, Eliana Sofía Espín Vaca, Eduardo Mauricio Espinel Lalama, Manuel Alejandro Navas Ortega, María Fernanda Naranjo Morales
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
